HDAC9 and hepatocellular carcinoma: On this basis, the current study is the first study that aims to evaluate the crosstalk of autophagy and apoptosis and the impact of a combination of epigenetic modulators including an HDAC inhibitor, Vorinostat with a demethylating agent, and Decitabine on the signaling nodes mediating this crosstalk in human HCC cells.